However, treatment of Olaparib in the PARP1 siRNA-transfected cells had no effect on cell proliferation, which may indicate that the tumor-suppressive effect of Olaparib is through inactivation of PARP1 (Figure 1D). The gene discussed is PARP1; the disease is neoplasm.